Injective gains 10% as leverage hits $164M – Can rising INJ bets sustain rally?

Injective [INJ] gained 10% in the early hours of the 10th of October as bullish trading activity picked up. Perpetual buying pressure and spot exchange outflows supported the outlook, with traders showing renewed interest in the asset. Alongside those moves, Injective’s updated white paper and ongoing exchange-traded fund (ETF) applications offered potential catalysts. Are INJ buyers taking the lead? Across exchanges, INJ’s Taker Buy/Sell Ratio reached 1.14 over the preceding four hours. A reading above 1 indicates that taker buying volume exceeded taker selling volume, pointing to stronger aggressive buying.

Source: AMBCrypto